Clinical implications of genetic polymorphisms on stomach cancer drug therapy

Pharmacogenomics J. 2007 Apr;7(2):76-80. doi: 10.1038/sj.tpj.6500405. Epub 2006 Jun 27.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Biotransformation / genetics
  • Fluorouracil / therapeutic use
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Genotype
  • Humans
  • Patient Selection*
  • Polymorphism, Single Nucleotide*
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / enzymology
  • Stomach Neoplasms / genetics*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Fluorouracil